MetLife, Inc. (NYSE:MET – Get Free Report) has earned a consensus rating of “Moderate Buy” from the fifteen brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $105.19.
A number of research analysts have weighed in on MET shares. Barclays boosted their target price on shares of MetLife from $97.00 to $111.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. Wells Fargo & Company raised their price target on MetLife from $109.00 to $110.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. Morgan Stanley lifted their price objective on MetLife from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, August 24th. Argus lifted their price objective on MetLife from $93.00 to $109.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Finally, Mizuho cut their price objective on MetLife from $112.00 to $109.00 and set an “outperform” rating for the company in a research report on Wednesday, October 7th.
Read Our Latest Research Report on MetLife
Institutional Investors Weigh In On MetLife
Several hedge funds have recently modified their holdings of the business. Mowery & Schoenfeld Wealth Management LLC bought a new position in MetLife during the second quarter worth $26,000. Burk Holdings LLC acquired a new position in MetLife during the 2nd quarter valued at $27,000. Nvwm LLC boosted its holdings in MetLife by 655.3% in the 3rd quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 249 shares during the period. Highland Investment Advisors LLC bought a new stake in MetLife in the 2nd quarter valued at $30,000. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new stake in MetLife in the 4th quarter valued at $31,000. 94.99% of the stock is owned by institutional investors.
Key Stories Impacting MetLife
Here are the key news stories impacting MetLife this week:
- Positive Sentiment: JPMorgan raised its price target for MetLife from $108 to $110 and maintained an “overweight” rating. The new target implies approximately 9% upside from the referenced share price, signaling continued confidence in MetLife’s earnings outlook and valuation.
- Positive Sentiment: Dowling & Partners increased its FY2026 EPS forecast to $10.30 from $10.10. The revised estimate is also above the broader consensus forecast of $9.90, suggesting expectations for stronger profitability. MetLife Hits New 52-Week High on Analyst Upgrade
- Positive Sentiment: MetLife reached a new 52-week high following an analyst upgrade. The move reflects sustained investor demand and momentum around the insurer’s earnings performance and analyst outlook. MetLife Hits New 52-Week High on Analyst Upgrade
- Positive Sentiment: Brokerages’ consensus price target is reported at $105.06, providing additional evidence that analysts see potential upside for MET. MetLife Consensus Price Target
- Neutral Sentiment: MetLife Foundation awarded a $1 million grant to Ascendus for its Get Ready program. The initiative supports financial preparedness and may enhance MetLife’s corporate reputation, but it is unlikely to materially affect near-term earnings. Ascendus Expands Get Ready Program
- Neutral Sentiment: Articles about concerts, NFL venues and events at MetLife Stadium concern the stadium’s entertainment operations, not MetLife, Inc.’s insurance and financial-services business, so they are not expected to influence MET materially.
MetLife Price Performance
Shares of MetLife stock opened at $100.73 on Thursday. The firm has a fifty day simple moving average of $96.87 and a 200-day simple moving average of $88.73. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52. MetLife has a 1-year low of $67.33 and a 1-year high of $102.43. The stock has a market capitalization of $64.82 billion, a price-to-earnings ratio of 19.30, a PEG ratio of 0.95 and a beta of 0.78.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business had revenue of $13.52 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the prior year, the firm earned $2.02 EPS. MetLife’s quarterly revenue was up 10.5% compared to the same quarter last year. On average, sell-side analysts expect that MetLife will post 9.93 earnings per share for the current year.
MetLife declared that its Board of Directors has approved a share repurchase program on Wednesday, August 5th that allows the company to repurchase $3.00 billion in shares. This buyback authorization allows the financial services provider to buy up to 4.8% of its shares through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its shares are undervalued.
MetLife Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Shareholders of record on Tuesday, November 3rd will be given a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, November 3rd. MetLife’s payout ratio is currently 45.40%.
About MetLife
MetLife, Inc is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products.
The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs.
Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe.
See Also
- Five stocks we like better than MetLife
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
